208 related articles for article (PubMed ID: 7798624)
1. Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption.
Wood LC; Elias PM; Sequeira-Martin SM; Grunfeld C; Feingold KR
J Invest Dermatol; 1994 Dec; 103(6):834-8. PubMed ID: 7798624
[TBL] [Abstract][Full Text] [Related]
2. Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin.
Wood LC; Stalder AK; Liou A; Campbell IL; Grunfeld C; Elias PM; Feingold KR
Exp Dermatol; 1997 Apr; 6(2):98-104. PubMed ID: 9209892
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
Wood LC; Jackson SM; Elias PM; Grunfeld C; Feingold KR
J Clin Invest; 1992 Aug; 90(2):482-7. PubMed ID: 1644919
[TBL] [Abstract][Full Text] [Related]
4. Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels.
Wood LC; Feingold KR; Sequeira-Martin SM; Elias PM; Grunfeld C
Exp Dermatol; 1994 Apr; 3(2):56-60. PubMed ID: 7921651
[TBL] [Abstract][Full Text] [Related]
5. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis.
Wood LC; Elias PM; Calhoun C; Tsai JC; Grunfeld C; Feingold KR
J Invest Dermatol; 1996 Mar; 106(3):397-403. PubMed ID: 8648167
[TBL] [Abstract][Full Text] [Related]
6. Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis.
Tsai JC; Feingold KR; Crumrine D; Wood LC; Grunfeld C; Elias PM
Arch Dermatol Res; 1994; 286(5):242-8. PubMed ID: 8060154
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous barrier repair and pathophysiology following barrier disruption in IL-1 and TNF type I receptor deficient mice.
Man MQ; Wood L; Elias PM; Feingold KR
Exp Dermatol; 1999 Aug; 8(4):261-6. PubMed ID: 10439223
[TBL] [Abstract][Full Text] [Related]
8. Mechanical and metabolic injury to the skin barrier leads to increased expression of murine β-defensin-1, -3, and -14.
Ahrens K; Schunck M; Podda GF; Meingassner J; Stuetz A; Schröder JM; Harder J; Proksch E
J Invest Dermatol; 2011 Feb; 131(2):443-52. PubMed ID: 20944649
[TBL] [Abstract][Full Text] [Related]
9. Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family.
Ye J; Garg A; Calhoun C; Feingold KR; Elias PM; Ghadially R
Exp Dermatol; 2002 Jun; 11(3):209-16. PubMed ID: 12102659
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of IL-1 and IL-1 receptor antagonist in HaCaT keratinocytes by tumor necrosis factor-alpha and transforming growth factor-beta 1.
Kang K; Hammerberg C; Cooper KD
Exp Dermatol; 1996 Aug; 5(4):218-26. PubMed ID: 8889469
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes.
Kutsch CL; Norris DA; Arend WP
J Invest Dermatol; 1993 Jul; 101(1):79-85. PubMed ID: 8331299
[TBL] [Abstract][Full Text] [Related]
12. Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis.
Liou A; Elias PM; Grunfeld C; Feingold KR; Wood LC
J Invest Dermatol; 1997 Jan; 108(1):73-7. PubMed ID: 8980291
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice.
Ottey KA; Wood LC; Grunfeld C; Elias PM; Feingold KR
J Invest Dermatol; 1995 Mar; 104(3):401-4. PubMed ID: 7861009
[TBL] [Abstract][Full Text] [Related]
14. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient.
Menon GK; Elias PM; Feingold KR
Br J Dermatol; 1994 Feb; 130(2):139-47. PubMed ID: 8123567
[TBL] [Abstract][Full Text] [Related]
15. The changes of epidermal calcium gradient and transitional cells after prolonged occlusion following tape stripping in the murine epidermis.
Ahn SK; Hwang SM; Jiang SJ; Choi EH; Lee SH
J Invest Dermatol; 1999 Aug; 113(2):189-95. PubMed ID: 10469302
[TBL] [Abstract][Full Text] [Related]
16. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin.
Nickoloff BJ; Naidu Y
J Am Acad Dermatol; 1994 Apr; 30(4):535-46. PubMed ID: 7512582
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis.
Wang XP; Schunck M; Kallen KJ; Neumann C; Trautwein C; Rose-John S; Proksch E
J Invest Dermatol; 2004 Jul; 123(1):124-31. PubMed ID: 15191552
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of mRNA for putative fatty acid transport related proteins and fatty acyl CoA synthase in murine epidermis and cultured human keratinocytes.
Harris IR; Farrell AM; Memon RA; Grunfeld C; Elias PM; Feingold KR
J Invest Dermatol; 1998 Nov; 111(5):722-6. PubMed ID: 9804328
[TBL] [Abstract][Full Text] [Related]
19. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
[TBL] [Abstract][Full Text] [Related]
20. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
